SCHEMBL1603435

SCHEMBL1603435

CCCCCCCCOCCCCCCCCSCCC(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 7/20 0.66
HSD17B10 Q99714 2/20 0.55
GMNN O75496 1/20 0.55
TP53 P04637 1/20 0.55
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
THRB P10828 1/20 0.55
CYP2C9 P11712 1/20 0.55
BLM P54132 1/20 0.55
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
E388 SCHEMBL30341080 0.96 PLA2G4B (0.65) PLA2G4BHSD17B10GPR84PPARGPPARD
SCHEMBL1603403 0.93 PLA2G4B (0.57) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL1603479 0.90 GPR84 (0.55) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL1603698 0.90 GPR84 (0.55) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL1527381 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL8865660 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL3135887 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL9015776 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL1603644 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB
SCHEMBL9185714 0.89 HSD17B10 (0.67) PLA2G4BHSD17B10GMNNTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663444-B2 Heteroatom containing substituted fatty acids COMPLEXA, INC. (US) 2017-05-30 US disclosed
US-20170113999-A9 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS COMPLEXA, INC. (US) 2017-04-27 US disclosed
US-20140256814-A1 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS COMPLEXA, INC. (US) 2014-09-11 US disclosed
EP-2483233-A2 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS Miller, Raymond A. (US) 2012-08-08 EP disclosed
WO-2011041639-A2 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS MILLER RAYMOND A (US) 2011-04-07 WO disclosed
US-20110082206-A1 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS COMPLEXA, INC. 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170113999-A9 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS FFAR2, FFAR1, FFAR4 PLA2G4B 129/4885HSD17B10 274/4885GMNN 4270/4885
US-20140256814-A1 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS FFAR2, FFAR1, FFAR4 PLA2G4B 129/4885HSD17B10 274/4885GMNN 4270/4885
US-20110082206-A1 HETEROATOM CONTAINING SUBSTITUTED FATTY ACIDS FFAR2, FFAR1, FFAR4 PLA2G4B 129/4885HSD17B10 274/4885GMNN 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.